Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review.
Laffont-Lozes P, Larcher R, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne JP, Sotto A, Loubet P. Laffont-Lozes P, et al. Among authors: larcher r. Antimicrob Resist Infect Control. 2023 Sep 12;12(1):100. doi: 10.1186/s13756-023-01302-3. Antimicrob Resist Infect Control. 2023. PMID: 37697357 Free PMC article. Review.
Effect of antimicrobial consumption on Escherichia coli resistance: assessment and forecasting using Dynamic Regression models in a French university hospital (2014-2019).
Laffont-Lozes P, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne JP, Sotto A, Larcher R. Laffont-Lozes P, et al. Among authors: larcher r. Int J Antimicrob Agents. 2023 May;61(5):106768. doi: 10.1016/j.ijantimicag.2023.106768. Epub 2023 Mar 4. Int J Antimicrob Agents. 2023. PMID: 36878409 Free article.
Correction: Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review.
Laffont-Lozes P, Larcher R, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne JP, Sotto A, Loubet P. Laffont-Lozes P, et al. Among authors: larcher r. Antimicrob Resist Infect Control. 2024 Mar 21;13(1):33. doi: 10.1186/s13756-024-01387-4. Antimicrob Resist Infect Control. 2024. PMID: 38515203 Free PMC article. No abstract available.
First case report of a vertebral osteomyelitis caused by carbapenem-resistant Enterobacter cloacae treated with imipenem/cilastatin/relebactam prolonged infusion then meropenem/vaborbactam in continuous infusion.
Laffont-Lozes P, Naciri T, Pantel A, Martin A, Pruvot-Occean AS, Haignere V, Loubet P, Sotto A, Larcher R. Laffont-Lozes P, et al. Among authors: larcher r. Front Pharmacol. 2024 Oct 30;15:1347306. doi: 10.3389/fphar.2024.1347306. eCollection 2024. Front Pharmacol. 2024. PMID: 39545060 Free PMC article.
Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID.
Soueges S, Faure E, Parize P, Lanternier-Dessap F, Lecuyer H, Huynh A, Martin-Blondel G, Gaborit B, Blot M, Magallon A, Blanchard E, Brousse X, Lahouati M, Brunel AS, Le Banner E, Camelena F, Larcher R, Pantel A, Melica G, Razazi K, Danion F, Schramm F, Dumitrescu O, Hoellinger B, Ader F; G2I (Groupe Immunodepression et Infections) network. Soueges S, et al. Among authors: larcher r. J Infect. 2024 Dec 15;90(1):106376. doi: 10.1016/j.jinf.2024.106376. Online ahead of print. J Infect. 2024. PMID: 39681233 Free article.
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients.
Bruel T, Vrignaud LL, Porrot F, Staropoli I, Planas D, Guivel-Benhassine F, Puech J, Prot M, Munier S, Bolland WH, Soulié C, Zafilaza K, Lusivika-Nzinga C, Meledge ML, Dorival C, Molino D, Péré H, Yordanov Y, Simon-Lorière E, Veyer D, Carrat F, Schwartz O, Marcelin AG, Martin-Blondel G; ANRS 0003S CoCoPrev Study Group. Bruel T, et al. Med. 2023 Oct 13;4(10):664-667. doi: 10.1016/j.medj.2023.07.007. Med. 2023. PMID: 37837962 Free PMC article.
Epidemiology, clinical and biological characteristics, and prognosis of critically ill COVID 19 patients: a single-center experience through 4 successive waves.
Tchakerian S, Besnard N, Brunot V, Moulaire V, Benchabane N, Platon L, Daubin D, Corne P, Machado S, Jung B, Bendiab E, Landreau L, Pelle C, Larcher R, Klouche K. Tchakerian S, et al. Among authors: larcher r. Pneumonia (Nathan). 2024 Nov 5;16(1):27. doi: 10.1186/s41479-024-00144-w. Pneumonia (Nathan). 2024. PMID: 39497221 Free PMC article.
175 results